AstraZeneca Offers $124 per Share in Cash to Acquire Rhythm Pharma. (Wall Street Journal)
AstraZeneca proposed to acquire Rhythm Pharma for $124 per share in cash. (The Wall Street Journal)
VolFlash analysisQueued
This event is in the analysis queue — usually done within 40s. Refresh to see it.
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Related events
Published：2026-11-04 21:01:41 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.